Abstract
The objective of this study was to evaluate the reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) in US patients with gastroesophageal reflux disease (GERD). Five hundred and sixteen adults with predominant heartburn symptoms of GERD were recruited from gastroenterologist and family physician practices and treated with 6 weeks of 150mg ranitidine twice daily to identify poorly responsive symptomatic GERD. The GSRS, the Medical Outcomes Study Short Form-36 (SF-36) Health Survey and the Psychological General Well-being (PGWB) scale were administered at baseline and after 6 weeks of treatment. Reported ratings of GERD-related symptoms from physician and patient diaries were measured. The GSRS contains five scales: reflux syndrome, abdominal pain, constipation syndrome, diarrhoea syndrome and indigestion syndrome. The internal consistency reliabilities for the GSRS scales ranged from 0.61 to 0.83 and the intraclass correlation coefficients ranged from 0.42 to 0.60. The GSRS scale scores were correlated with the SF-36 and PGWB scales and with the number and severity of heartburn symptoms. Patients with two or three clinician-rated GERD-related symptoms reported worse GSRS scale scores compared with patients with fewer symptoms (p < 0.0001). Statistically significant differences in the mean GSRS scale scores were observed between treatment responders and non-responders (p < 0.0001) and patients showing a response to treatment had larger mean changes in their GSRS scales than patients not showing a response to treatment (p < 0.0001). The standardized response means ranged from 0.42 to 1.43 for the GSRS scale scores. It was concluded that the GSRS is a brief, fairly comprehensive assessment of common gastrointestinal symptoms. The GSRS has good reliability and construct validity and the GSRS scales discriminate by GERD symptom severity and are responsive to treatment. The GSRS is a useful patient-rated symptom scale for evaluating the outcomes of treatment for GERD.
Similar content being viewed by others
References
Revicki DA. Health care technology and health-related quality of life. In: Banta D, Luce B eds. Health Care Technology and its Assessment: an International Perspective. New York: Oxford University Press, 1993: 114–131.
Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med 1996; 334: 835–840.
Wiklund I. Aspects of quality of life in gastrointestinal disease: some methodological issues. Scand J Gastroenterol 1995; 30(Suppl 208): 129–132.
Martin C, Marquis P, Bonfils S. A quality of life questionnaire adapted to duodenal ulcer therapeutic trials. Scand J Gastroenterol 1994; 29Suppl 206: 40–43.
Irvine EJ. Quality of life-rationale and methods for developing a disease-specific instrument for inflammatory bowel disease. Scand J Gastroenterol 1993; 28(Suppl 199); 22–27.
Drossman DA, Leserman J, Li Z et al. The rating form of IBD patients concerns: a new measure of health status. Psychosom Med 1991; 53: 701–712.
Chal KL, Stacey JH, Sacks GE. The effect of ranitidine on symptom relief and quality of life of patients with gastrooesophageal reflux disease. Br J Clin Pract 1995; 49: 73–77.
Rush DR, Stelmach WJ, Young TL et al. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study. J Family Pract 1995; 41: 126–136.
Stacey JH, Miocevich ML, Sacks GE. The effect of ranitidine (as effervescent tablets) on the quality of life of GERD patients. Br J Clin Pract 1996; 50: 190–196.
Stewart AL, Greenfield S, Hays RD et al. Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study. JAMA 1989; 262: 907–913.
Dimenas E, Glise H, Hallerback B et al. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995; 30: 1046–1052.
Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig Dis Sci 1995; 40: 584–589.
Drossman DA, Li Z, Toner BB et al. Functional bowel disorders: a multicenter comparison of health status and development of illness severity index. Dig Dis Sci 1995; 40: 986–995.
Guyatt G, Mitchell A, Irvine EJ et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989; 96: 804–810.
Talley NJ, Phillips SF, Melton J III et al. A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 111: 671–674.
Locke GR, Talley NJ, Weaver AL et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 539–547.
Svedlund J, Sjodin I, Dotevall G. GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33: 129–134.
Dimenas E, Glise H, Hallerback B et al. Quality of life in patients with upper gastrointestinal symptoms: an improved evaluation of treatment regimens? Scand J Gastroenterol 1993; 28: 681–687.
Glise H, Hulterback B, Johansson B. Quality of life assessments in the evaluation of gastrointestinal reflux and peptic ulcer disease before, during and after treatment. Scan J Gastroenterol 1995; 30(Suppl 208): 133–135.
Revicki DA, Leidy NK, Howland L. Evaluating the psychometric characteristics of the psychological general well-being index with a new response scale. Qual Life Res 1996; 5: 417–423.
Ware JE Jr, Snow KK, Kosinski M et al. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center, 1993.
Ware JE Jr, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: The Health Institute, New England Medical Center, 1994.
Dupuy H. The Psychological General Well-Being (PGWB) index. In: Wenger NK, Mattson ME, Furberg CD, Elinson J, eds. Assessment of Quality of Lfe in Clinical Trials of Cardiovascular Therapies. Greenwich, CT: Le Jacq Publishing, 1984: 170–183.
Dimenas E, Carlsson G, Glise H et al. The relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol 1996; 31(Suppl 221): 8–13.
Revicki DA, Allen H, Bungay K et al. Responsiveness and calibration of the general well-being adjustment scale in patients with hypertension. J Clin Epidemiol 1994; 47: 1333–1342.
Nunnally JC. Psychometric theory, 2nd edn. New York: McGraw-Hill, 1978.
Cronbach L. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297–334.
Bartko J. The intraclass correlation coefficient as a measure of reliability. Psychol Rep 1966; 19: 3–11.
Katz JN, Larson MG, Phillips CB, et al. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992; 30: 917–925.
Adelman A, Revicki D, Magaziner J, Hebel R. Abdominal pain in an HMO. Family Med 1995; 27: 321–325.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Revicki, D.A., Wood, M., Wiklund, I. et al. Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Qual Life Res 7, 75–83 (1997). https://doi.org/10.1023/A:1008841022998
Issue Date:
DOI: https://doi.org/10.1023/A:1008841022998